Patents expiring in 2032

US 8252578

Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof

Xenon Pharmaceuticals Inc. · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8252764

Compositions and methods of use of targeting peptides against placenta and adipose tissues

The Board of Regents of the University of Texas System · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8252767

Substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists

Dogwood Pharmaceuticals, Inc. · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8252756

Nucleic acid functionalized nanoparticles for therapeutic applications

Northwestern University · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8252787

Protein kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8252807

Methods of inhibiting the interaction between S100 and the receptor for advanced glycation end-products

The Board of Regents of the University of Texas System · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8252841

Methods of inhibiting bacterial virulence and compounds relating thereto

The Board of Regents of the University of Texas System · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8252814

Agents and crystals for improving excretory potency of urinary bladder

Takeda Pharmaceutical Company Limited · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8252845

Pterostilbene as an agonist for the peroxisome proliferator-activated receptor alpha isoform

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8252933

2-oxo-1,2-dihydro-quinoline modulators of immune function

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8252937

1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones

Addex Pharma, S.A. · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8252926

Process for the preparation of imatinib base

Mustafa Nevzat llaç Sanayii A.S. · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8252541

Sodium channel protein type III α-subunit splice variant

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2491925

Antitumorigene Kombinaton, die Cabazitaxel und Cisplatin umfasst

AVENTIS PHARMA SA [FR] · Granted Wed Aug 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Aug 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8258278

Methods and compositions for the treatment and prevention of cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8258163

Small-molecule agonists for type-2 orexin receptor

The Board of Regents of the University of Texas System · Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8258148

Spiroindoline modulators of muscarinic receptors

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8258324

Intermediates useful in the preparation of maleimide functionalized polymers

Nektar Therapeutics · Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8258257

Claudin-4 binding peptides, compositions and methods of use

The Regents of the University of California · Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8258142

Substituted 8-[6-amino-3-pyridyl]xanthines

Dogwood Pharmaceuticals, Inc. · Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8257915

Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8257932

Interfacing nanostructures to biological cells

The Regents of the University of California · Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8258263

Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities

The Regents of the University of California · Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8258274

Vaccines containing canine parvovirus genetic variants

The Board of Regents for Oklahoma State University · Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8258122

3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives

Almirall, S.A. · Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8258252

Sustained-release composition and process for producing the same

Takeda Pharmaceutical Company Limited · Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8257699

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

HALOZYME, INC. · Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8258116

Combination therapy for the treatment of HCV infection

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8257918

Intelligent nanomedicine integrating diagnosis and therapy

The Regents of the University of California · Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8258106

Immunostimulatory nucleic acid molecules

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8257719

Oral care layer and related method of manufacture

Ranir, LLC · Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8258308

Amino nicotinic and isonicotinic acid derivatives as DHODH inhibitors

Laboratories Almirall, S.A. · Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8258280

Plasmodium vivax hybrid circumsporozoite protein and vaccine

The United States of America as represented by the Secretary of the Army · Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

FR 2972192

COMPOSITION PHARMACEUTIQUE DESTINEE A LA PREVENTION OU AU TRAITEMENT DES CANCERS

BIOCODEX [FR] · Granted Fri Sep 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Sep 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8263657

Inhibitors against the production and release of inflammatory cytokines

Institute of Medicinal Molecular Design, Inc. · Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8263677

Removable color gel basecoat for artificial nail coatings and methods therefore

Creative Nail Design Inc. · Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8263632

Aminopyridine derivatives having Aurora A selective inhibitory action

Vertex Pharmaceuticals Incorporated · Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8263618

8-azabicyclo[3.2.1]octane compounds as MU opioid receptor antagonists

Theravance, Inc. · Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8263661

Development of new selective estrogen receptor modulators

The Regents of the University of California · Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8263650

Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

Jazz Pharmaceuticals, Inc. · Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8263651

Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to treat conditions mediated by PBR, CB2, and NK2 receptors

The Regents of the University of California · Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8263662

Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products

The Regents of the University of California · Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8263759

Sets of probes and primers for the diagnosis of select cancers

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8263747

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

The Regents of the University of California · Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8263588

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8263085

Gammaretrovirus associated with cancer

The Regents of the University of California · Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8263572

RNAi modulation of RSV and therapeutic uses thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8263102

Drug delivery coating for use with a stent

ATRIUM MEDICAL CORPORATION · Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)